Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 2014

View Archived Issues

Development of adipocyte-specific lactate receptor inhibitor for the treatment of dyslipidemia

RaQualia Pharma reports data on novel ghrelin receptor agonist

Potentially heat-stable HBV oral vaccine candidate presented

Adjuvanted pertussis vaccine with enhanced protection and thermal stability

Novel homoisoflavonoid analogue for the inhibition of angiogenesis

GSK presents highlights of first quarter 2014

Antipsychotic efficacy of phosphodiesterase inhibition compared with dopamine receptor blockade

Selective lipopeptide nanoparticle-mediated gene silencing of hepatocytes in preclinical models

Novel therapeutic targeting an alternate angiogenic signal pathway

Pre-IBD Consortium formed to research on IBD prevention

Selexys and Cytovance form antibody manufacturing agreement

Double-blind trial finds (S)-(-)-OSU-6162 effective in treating alcohol dependence

Naurex reports topline phase IIb data for GLYX-13 and advances NRX-1074

reMYND's novel diabetes treatment prevents disease progression in mouse model

biOasis peptide vector delivers siRNA to brain

Erytech cleared to begin phase II study ERY-ASP in pancreatic cancer in France

Evotec and Eternygen to identify and develop novel metabolic disease therapy

Ablynx's ALX-0171 completes two further phase I studies

Apitope begins preclinical development for ATX-F8-117

Novel orexin receptor antagonists disclosed by Actelion Pharmaceuticals

Japanese researchers present new agents for cancer

Hoffmann-La Roche discloses novel mGlu5 receptor positive allosteric modulators

Janssen R&D Ireland designs new TLR7/TLR8 receptor agonists

New anticancer agents patented by Chinese scientists

Antiplatelet agent vorapaxar approved by FDA

TGen and George Mason University form genomics and proteomics alliance

Anoro Ellipta approved in E.U. for COPD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...